Gender (n) | Male 16 Female 13 | Hypoglycemic agent (n) | Â |
Age (years) | 58.9±11.0 | OHA | 16 |
BMI (kg/m 2 ) | 26.2±5.4 | Insulin | 2 |
Diabetes duration (years) | 14.4±6.2 | OHA + insulin | 10 |
HbA1c (%) | 8.3±1.6 | Antihypertensive agent (n) |  |
Diabetic complications (n) | Â | CCB | 17 |
 Neuropathy | 18 | ARB | 21 |
 Retinopathy | 9 | ACE inhibitor | 4 |
 Nephropathy | 13 | Diuretic | 3 |
Macrovascular disease (n) | Â | Î’ blocker | 2 |
 Cerebral infarction | 4 | Antihyperlipidemic agent (n) |  |
 Angina/myocardial infarction | 4 | Statin | 17 |
 |  | Ezetimibe | 1 |
 |  | Antiplatelet agent (n) |  |
 |  | Aspirin | 5 |
 |  | Clopidogrel | 1 |